# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058165
Filing Date
2023-11-02
Accepted
2023-11-02 16:05:47
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sndx-20230930.htm iXBRL | 10-Q | 2376294
2 | EX-31.1 | sndx-ex31_1.htm | EX-31.1 | 14878
3 | EX-31.2 | sndx-ex31_2.htm | EX-31.2 | 15237
4 | EX-32.1 | sndx-ex32_1.htm | EX-32.1 | 14820
| Complete submission text file | 0000950170-23-058165.txt |  | 9724340

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sndx-20230930_def.xml | EX-101.DEF | 196347
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sndx-20230930_cal.xml | EX-101.CAL | 45861
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sndx-20230930_lab.xml | EX-101.LAB | 406763
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sndx-20230930_pre.xml | EX-101.PRE | 308465
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sndx-20230930.xsd | EX-101.SCH | 55255
57 | EXTRACTED XBRL INSTANCE DOCUMENT | sndx-20230930_htm.xml | XML | 2273352

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 231372208
SIC: 2834 Pharmaceutical Preparations